(19)
(11) EP 1 114 861 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.10.2008 Bulletin 2008/40

(45) Mention of the grant of the patent:
29.11.2006 Bulletin 2006/48

(21) Application number: 99943357.6

(22) Date of filing: 16.09.1999
(51) International Patent Classification (IPC): 
C12N 15/12(2006.01)
C12N 5/10(2006.01)
C07K 16/28(2006.01)
A61K 38/17(2006.01)
G01N 33/68(2006.01)
C12N 15/63(2006.01)
C07K 14/705(2006.01)
C12Q 1/68(2006.01)
A61K 48/00(2006.01)
(86) International application number:
PCT/JP1999/005039
(87) International publication number:
WO 2000/017345 (30.03.2000 Gazette 2000/13)

(54)

LY6H GENE

LY6H-GEN

GENE LY6H


(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 17.09.1998 JP 26355098

(43) Date of publication of application:
11.07.2001 Bulletin 2001/28

(73) Proprietor: Otsuka Pharmaceutical Co., Ltd.
Tokyo 101-8535 (JP)

(72) Inventors:
  • HORIE, Masato
    Naruto-shi, Tokushima 772-0051 (JP)
  • OKUTOMI, Keiichi c/o OTSUKA PHARMACEUTICAL CO.LTD.
    Tokushima 771-0192 (JP)
  • TANIGUCHI, Yoshihiro
    Tokushima-shi, Tokushima 771-0125 (JP)
  • SUZUKI, Mikio c/o OTSUKA PHARMACEUTICAL CO.LTD.
    Tokushima 771-0192 (JP)
  • OHBUCHI, Yutaka
    Tokushima-shi, Tokushima 771-0130 (JP)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München
81925 München (DE)


(56) References cited: : 
WO-A-97/18224
JP-A- 3 048 696
   
  • DATABASE EMBL EBI; 31 August 1995 (1995-08-31) FUJIWARA T. ET AL.: "Human fetal brain cDNA 5'-end GEN-425G08" retrieved from EBI Database accession no. D61641 XP002291885
  • BRAKENHOFF R H ET AL: "THE HUMAN E48 ANTIGEN, HIGHLY HOMOLOGOUS TO THE MURINE LY-6 ANTIGEN THB, IS A GPI-ANCHORED MOLECULE APPARENTLY INVOLVED IN KERATINOCYTE CELL-CELL ADHESION" JOURNAL OF CELL BIOLOGY, ROCKEFELLER UNIVERSITY PRESS, NEW YORK, US, US, vol. 129, no. 6, 1 June 1995 (1995-06-01), pages 1677-1689, XP000563620 ISSN: 0021-9525
  • MAO M ET AL: "RIG-E, A HUMAN HOMOLOG OF THE MURINE LY-6 FAMILY, IS INDUCED BY RETINOIC ACID DURING THE DIFFERENTIATION OF ACUTE PROMYELOCYTIC LEUKEMIA CELL" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 93, no. 12, 11 June 1996 (1996-06-11), pages 5910-5914, XP002044081 ISSN: 0027-8424
  • CRAY C ET AL: "Regulation and selective expression of Ly-6A/E, a lymphocyte activation molecule, in the central nervous system." BRAIN RESEARCH. MOLECULAR BRAIN RESEARCH. JUN 1990, vol. 8, no. 1, June 1990 (1990-06), pages 9-15, XP002291818 ISSN: 0169-328X
  • HORIE M. ET AL.: 'Isolation and Chararacterization of New Member of the Human Ly6 Gene Family (LY6H)' GENOMICS vol. 53, November 1998, pages 365 - 368, XP002932440
  • FLEMING T.J. ET AL.: 'Characterization of Two Novel Ly-6 Genes' J. IMMUNOL. vol. 150, no. 12, 1993, pages 5379 - 5390, XP002932441
  • FRIEDMAN S. ET AL.: 'Analysis of three distinct Ly6-A-related cDNA sequences isolated from rat kidney' IMMUNOGENETICS vol. 31, no. 2, 1990, pages 104 - 111, XP002932442
  • GRAUBERT T. ET AL.: 'Characterization of the murine and human Ly-6 gene clusters' BLOOD vol. 90, no. 1, 1997, page 145B, PART 2, NR. 3363, XP002932443
  • NOSTEN-BERTRAND M. ET AL.: 'Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1' NATURE vol. 379, 1996, pages 826 - 829, XP002932444
  • GUMLEY T.P. ET AL.: 'Tissue expression structure and function of the murine Ly-6 family of molecules' IMMUNOL. AND CELL. BIOL. vol. 73, no. 4, 1995, pages 277 - 296, XP002932445
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).